Clover Health Investments, Corp. (NASDAQ:CLOV) saw a 19.37% surge on Friday due to a "buy" recommendation from Zacks Research, with earnings estimates showing promise. Analysts anticipate $0.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing